Dadimashtaka Churna: Traditional Uses, Evidence & Safety

Q: What is Dadimashtaka Churna?

A 14ingredient Ayurvedic digestive powder whose chief ingredient is pomegranate (Dadima), with spices, Trikatu, and a large sugar base, classically described in Bhaishajya Ratnavali for Grahanitype intestinal disorders.

TL;DR

Dadimashtaka Churna is a 14-ingredient Ayurvedic powder built around pomegranate (Dadima), described in Bhaishajya Ratnavali for Grahani (malabsorption-type intestinal disorders). The modern literature contains one narrative review of the formulation. No clinical trial, animal study, or safety study. This is a short article because that is all the evidence there is.

What it is

The name says it plainly: Dadima (pomegranate, Punica granatum) is the chief ingredient. The churna is a dry powder of 14 ingredients in specified parts. Tawaksheeri is 1 part. Twak, Patra, Ela, Nagakesara, Ajamoda, Dhanyaka, Ajaji, Granthi, Shunti (dry ginger), Maricha (black pepper), Pippali (long pepper), and Dadima are 2 parts each. Sita (sugar) is 16 parts: the largest single component by far (Narang & Herswani, 2018).

Note what the formula contains. Three pungents (Shunti, Maricha, Pippali, the Trikatu trio), carminative spices (Ela, Patra, Ajamoda, Dhanyaka, Ajaji), and astringent barks and flowers (Twak, Nagakesara). Bamboo manna (Tawaksheeri), pomegranate, and a large sugar base. The review describes its overall Ayurvedic pharmacology as Deepana (appetite-stimulating), Pachana (digestive), and Grahi (stool-binding, absorbent). With Katu (pungent) and Tikta (bitter) taste and Ushna (heating) potency (Narang & Herswani, 2018).

Traditional use

Acharya Govind Das Sen describes Dadimashtaka Churna in Bhaishajya Ratnavali, Grahani Rogadhikara: the chapter on Grahani disorders. The review lists its classical roga karma (disease actions): Athisara (diarrhea), Grahani, Ajeerna (indigestion), Agnimandya (weak digestive fire), and Arochaka (loss of taste/appetite). It summarizes the literature view: the formula is "a very good formulation for the management of diarrhea, dysentery, indigestion and irritable bowel syndrome" (Narang & Herswani, 2018). These are traditional attributions from a literature review. Not findings of any experiment.

What modern research says

Formulation review (narrative, 2018)

Narang and Herswani's paper is a narrative Ayurveda review: it compiles the composition, classical pharmacology (Rasa-Panchaka), preparation method, and traditional indications of Dadimashtaka Churna. It reports no new experiment, no trial, and no patient data. Its value is documentary: it pins down the 14-part composition and the Bhaishajya Ratnavali reference in one peer-reviewed place (Narang & Herswani, 2018).

What the evidence does not support (yet)

No clinical trials. Nothing in humans: for diarrhea, IBS, or anything else.
No animal or mechanism studies. The Deepana/Pachana/Grahi actions are classical pharmacological attributions, not demonstrated pharmacology.
No safety studies. The review itself only cautions that the formula's large sugar content warrants care in diabetic patients: a sensible inference from composition, not a study finding.

Safety & contraindications

No safety studies exist. What can be said from the composition:

High sugar content. Sita is 16 of 41 total parts: the review explicitly advises caution in diabetic patients (Narang & Herswani, 2018).
Heating, pungent formula. With Trikatu and Ushna virya, it is traditionally unsuited to conditions of excess heat or acidity: a classical consideration, not a studied contraindication.
Diarrhea needs proper assessment. Persistent diarrhea, dysentery, or blood in stool require medical evaluation; a traditional powder is not a substitute for diagnosis.
No data on pregnancy, breastfeeding, children, or drug interactions. Use under practitioner supervision.

FAQs

What is Dadimashtaka Churna?

A 14-ingredient Ayurvedic digestive powder whose chief ingredient is pomegranate (Dadima), with spices, Trikatu, and a large sugar base, classically described in Bhaishajya Ratnavali for Grahani-type intestinal disorders.

Does it work for diarrhea or IBS?

No clinical trial has tested it. Its reputation for diarrhea, dysentery, indigestion, and IBS-like complaints is entirely traditional, summarized in a 2018 narrative review.

What is the recommended dose?

The review mentions a traditional recommendation of 3–5 g with warm water or rice soup after meals. Our editorial rule requires a pharmacopoeial or clinical-trial dose, and a review's report of traditional practice meets neither bar. So we state no dose. The sugar content also means anyone with diabetes should be especially cautious and seek practitioner advice rather than self-dosing.

Is it safe for diabetics?

Probably not without supervision. Sugar is the single largest ingredient. The 2018 review itself flags caution for diabetic patients.

Annotated Sources

The 14-part composition table, Ayurvedic pharmacology (Deepana, Pachana, Grahi; Katu/Tikta rasa; Ushna virya), the Bhaishajya Ratnavali (Grahani Rogadhikara, Acharya Govind Das Sen) reference, traditional indications (Athisara, Grahani, Ajeerna, Agnimandya, Arochaka), and the diabetes caution are from Narang & Herswani, "Ayurveda review on 'Dadimashtaka Churna' and its clinical importance," Journal of Drug Delivery and Therapeutics 8(4):80–82, 2018 (PDF).

[Lavan Bhaskar Churna](/learn/herbs/lavan-bhaskar-churna) (another classical digestive churna)
[Vaiswanara Churna](/learn/herbs/vaiswanara-churna) (another classical churna for digestion and Vata)

Disclaimer

This article is for educational purposes only and is not medical advice. Dadimashtaka Churna has no clinical trials and no safety studies; its indications are traditional. It contains a large proportion of sugar and should be used cautiously by people with diabetes. Persistent digestive symptoms need proper medical assessment. Use only products from reputable manufacturers and only under the supervision of a qualified practitioner — especially if pregnant, breastfeeding, managing a medical condition, giving it to a child, or taking prescription medicines.